HAIFA, ISRAEL — Matthias H. Kreuter, Ph.D., has been appointed global chief scientific officer for the Frutarom Switzerland Ltd. Health Business Unit, effective Jan. 1.
Dr. Kreuter owns 18 patents. He received a Ph.D. in physiological chemistry and cancer pharmacology from the Faculty of Medicine at Johannes Gutenberg University in Mainz, Germany, and a degree in pharmacy from the Faculty of Pharmacy there. Dr. Kreuter headed Frutarom’s pharmaceutical business division from 1990 to 2003.
Dr. Kreuter will report to Holger Riemensperger, general manager of the global business unit, health, for Frutarom.
“Dr. Kreuter’s skill set, bolstered by his many years of experience, will help us lead Frutarom to the next level via high-impact growth, not only in the dietary supplements industry, but also in the food, beverage and pharmaceuticals industries,” Mr. Riemensperger said.
